検索キーワード： 薬理学

日本で最もたくさんのワクチンを商品として販売してきた製薬会社。その会社で若手のホープとして期待を集めていた影山晃大氏が、26歳で突然の死を遂げた。原因は、2回目のコロナワクチン接種。

妊娠中毒症、切迫早産、切迫流産のママがあなたのパートナーなら聴いておくとママの気持ちを理解できます。

In 2023, Johann Hari began injecting himself with one of the weight loss drugs transforming how we look, feel and live. What began as a personal journey soon took him on an international investigation, tackling some of the most world-changing issues as he asked: Who should be taking these medications? How are they set to change not only the way we think about weight loss, but our economies? What are the benefits – and what are the risks?

For Blood and Money tells the little-known story of how an upstart biotechnology company created a one-in-a-million cancer drug and how the core team—denied their share of the profits—went and did it again. In this epic saga of money and science, veteran financial journalist Nathan Vardi explains how the invention of two of the biggest cancer drugs in history became (for their backers) two of the greatest Wall Street bets of all time.

Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research. Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing - atom by atom - both a new life-saving immunosuppressant drug and a drug to combat the virus that causes AIDS.

Three out of four people addicted to heroin probably started on a prescription opioid, according to the director of the Centers for Disease Control and Prevention. In the United States alone, 16,000 people die each year as a result of prescription opioid overdose. But perhaps the most frightening aspect of the prescription drug epidemic is that it's built on well-meaning doctors treating patients with real problems.

From an award-winning Fortune reporter, an explosive narrative investigation of the generic drug boom that reveals the life-threatening dangers posed by globalization—The Jungle for pharmaceuticals The widespread use of generic drugs has been hailed as one of the most important public health...

During her two decades at The New England Journal of Medicine, Dr. Marcia Angell had a front-row seat on the appalling spectacle of the pharmaceutical industry. She watched drug companies stray from their original mission of discovering and manufacturing useful drugs and instead become vast...

Pain is an inevitable part of existence, but severe debilitating or chronic pain is a pathological condition that diminishes the quality of life. The Brain and Pain explores the present and future of pain management, providing a comprehensive understanding based on the latest discoveries from many branches of neuroscience. Richard Ambronthe former director of a neuroscience lab that conducted leading research in this fieldexplains the science of how and why we feel pain.

Whether you are a PharmD, PhD, MD, DPT, DC, or DNP, you likely have a credit card, student loan, and/or mortgage debt you would like to pay down. While your professors worked hard to teach you the ins and outs of clinical practice, it's unlikely they talked about personal finance as often making money is an anathema to being a good clinician and an unwelcome conversation. While debt prevention isn't as sexy as the person who overcame hundreds of thousands of student loan debt, the principles that the authors follow can help you find yourself in a much better financial place.

Retail pharmacy stands at a breaking point. Burnout is rising. Staffing is collapsing. Automation is accelerating. Unionization is no longer a theory. It is a response and behind the counter, professionals are holding the system together through sheer will. The Ghost of Pharmacies’ Future is a clear-eyed look at where pharmacy is headed if nothing changes. And what happens if we act now. Written by an industry insider, this audiobook blends real frontline experience with strategic insight.

With triplet eight-year-old daughters, I don't get four-hour study blocks in a quiet corner of the library. I get an hour here or 15 minutes there. This book is for those commuters, busy parents, and working students who need a "fit it in" approach to studying pharmacology. This book has multiple rapid-fire questions, answers, rationales, and mnemonics that you can do alone or with a partner to help you understand pharmacology better and remember the content longer.

This is perhaps one of the best-loved of all journals. William Wordsworth's sister, Dorothy, began it in May 1800 and resolved to keep it for a short time. She continued it for nearly three years. In it, she brought the Dove Cottage years to vivid and intimate life. She noted the walks and weather, the friends, country neighbours, and travellers on the roads. She set down accounts of the garden, of Wordsworth's marriage, their concern for Coleridge, and the composition of Wordsworth's poetry.

The 20th century saw a remarkable upsurge of research on drugs, with major advances in the treatment of bacterial and viral infections, heart disease, stomach ulcers, cancer, and metal illnesses. These, along with the introduction of the oral contraceptive, have altered all of our lives. There has also been an increase in the recreational use and abuse of drugs in the Western world. This Very Short Introduction, in its second edition, gives a nontechnical account of how drugs work in the body.

Unlock the science of you-at-your-best with Powerhouse Peptides for Women Over 30! This beginner's guide pulls back the curtain on nature's most potent messengers — short chains of amino acids known as peptides — and shows you exactly how to harness their regenerative magic for radiant skin, lean muscle, balanced hormones, and boundless energy. I also discuss bioregulators, which are loved within the peptide community. And I go over what I consider the Four Key Pillars of Health.

Rapamycin is one of the most intriguing—and controversial—compounds in modern longevity science. Originally developed as an immunosuppressant, it has moved from transplant medicine into the center of debates surrounding aging, healthspan, and cellular biology.

What if the story we trusted was not the whole truth? What if fear, not facts, drove our choices? What if asking questions is not risky but essential?

Pharmacology doesn't have to feel like drowning. You need to know these medications cold—not just for exams, but for safe patient care. Most pharm resources dump hundreds of facts and expect your brain to sort it out. Sound familiar? You're memorizing drug names but forgetting them days later. You can't keep classes straight. You're mixing up side effects between similar medications. You freeze recalling contraindications under pressure. You're worried you won't remember what matters when you're at a patient's bedside.

BPC-157: The Promise and Perils of a Healing Peptide is a clear-eyed exploration of one of the most talked-about compounds in modern recovery and biohacking. Originally studied for its potential effects on tissue repair and gut health, BPC-157 has drawn attention for its reported ability to support tendon healing, inflammation reduction, and recovery. While promising animal research has fueled interest, the absence of large-scale human trials leaves important questions about safety, regulation, and long-term effects.

Seguramente tienes déficit de magnesio y no lo sabes Vivimos en una sociedad en la que la fatiga constante, el estrés crónico y el insomnio han dejado de ser excepciones para convertirse en la norma. Este libro revela por qué el déficit de magnesio, tan frecuente como infradiagnosticado, es...